[HTML][HTML] EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

M Weller, M van den Bent, M Preusser… - Nature reviews Clinical …, 2021 - nature.com
In response to major changes in diagnostic algorithms and the publication of mature results
from various large clinical trials, the European Association of Neuro-Oncology (EANO) …

Glioblastoma: clinical presentation, diagnosis, and management

C McKinnon, M Nandhabalan, SA Murray, P Plaha - Bmj, 2021 - bmj.com
• Early symptoms of brain tumours in adults are non-specific, and patients may present
multiple times to primary care services before they are referred for investigation. Look for …

Current and future trends on diagnosis and prognosis of glioblastoma: from molecular biology to proteomics

AS Silantyev, L Falzone, M Libra, OI Gurina… - Cells, 2019 - mdpi.com
Glioblastoma multiforme is the most aggressive malignant tumor of the central nervous
system. Due to the absence of effective pharmacological and surgical treatments, the …

Epidemiology of glioma: Clinical characteristics, symptoms, and predictors of glioma patients grade I–IV in the the Danish Neuro-Oncology Registry

BK Rasmussen, S Hansen, RJ Laursen… - Journal of Neuro …, 2017 - Springer
In this national population-based study of glioma, we present epidemiologic data on
incidence, demographics, survival, clinical characteristics and symptoms, and evaluate the …

Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review

M IJzerman-Korevaar, TJ Snijders, A de Graeff… - Journal of neuro …, 2018 - Springer
Background Glioma patients suffer from a wide range of symptoms which influence quality of
life negatively. The aim of this review is to give an overview of symptoms most prevalent in …

TfR Aptamer Enhanced Blood‐Brain Barrier Penetration of Biomimetic Nanocomplexes for Intracellular Transglutaminase 2 Imaging and Silencing in Glioma

J Su, Z Yao, Z Chen, S Zhou, Z Wang, H Xia, S Liu… - Small, 2022 - Wiley Online Library
Engineering a versatile nanocomplex integrating effective penetration of the blood‐brain
barrier (BBB), accurate diagnosis, and boosting therapy has always been an intractable …

Targeting glioblastoma: Advances in drug delivery and novel therapeutic approaches

E Yeini, P Ofek, N Albeck… - Advanced …, 2021 - Wiley Online Library
Glioblastoma (GB) is the most lethal type of primary tumor in the central nervous system.
Current treatments include surgical resection followed by chemotherapy and radiotherapy …

Aptamer generated by cell-SELEX for specific targeting of human glioma cells

N Lin, L Wu, X Xu, Q Wu, Y Wang, H Shen… - … Applied Materials & …, 2020 - ACS Publications
The most prevalent primary brain tumors are gliomas, which start in the glial cells. Although
there have been significant technological advances in surgery and radio-chemotherapy, the …

Cognitive disability in adult patients with brain tumors

FS Ali, MR Hussain, C Gutiérrez, P Demireva… - Cancer treatment …, 2018 - Elsevier
Cognitive dysfunction is common among patients with intracranial tumors. Most cognitive
deficits are subtle, lack specificity, may mimic depression or other neurological disorders …

The roles of exosomes as future therapeutic agents and diagnostic tools for glioma

X Wu, X Wang, J Wang, Y Hao, F Liu, X Wang… - Frontiers in …, 2021 - frontiersin.org
Glioma is a common type of tumor originating in the brain. Glioma develops in the gluey
supporting cells (glial cells) that surround and support nerve cells. Exosomes are …